Exclusive

Publication

Byline

Sanofi, Translate Bio to develop mRNA vaccines across all infectious disease areas

Singapore, June 26 -- Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2... Read More


Australia to study first interventional neuromodulation platform

Singapore, June 26 -- US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbourne has been awarded an AUD$1.5M Medical Research Future Fund g... Read More


Panthera, Rutherford Health launch innovative oncology clinical trial network

Singapore, June 25 -- Panthera and Rutherford Health plc have entered a collaboration to create a network of world-class clinical trial sites for the development of new cancer treatments. The collabor... Read More


Novel technology Generates Biocatalysts for Biodiesel Production

Singapore, June 25 -- A research team from the School of Life Sciences at The Chinese University of Hong Kong (CUHK) has developed a novel method for extracting enzymes from bacteria, which lowers the... Read More


Gencurix wins FDA EUA for COVID-19 test kit

Singapore, June 25 -- A Korean molecular diagnostic company, Gencurix, Inc., has announced that they have received U.S. Food and Drug Administration (FDA)'s Emergency Use Authorization (EUA) for its G... Read More


Neoteryx gets blood collection device registered in Australia

Singapore, June 25 -- The Mitra(R) microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) medical device with the Therapeutic Goods Administration (TG... Read More


Singapore designs shield to protect COVID-19 healthcare workers

Singapore, June 25 -- A team of researchers from the National University of Singapore (NUS) has invented a foldable tent-like device that serves as a physical shield to reduce the risk of exposure to ... Read More


Australia announces $12M more funds for CVD research

Singapore, June 25 -- The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research to improve treatment of people, including children, suffe... Read More


"Portable Droplet and Aerosol Reducing Tent (DART)" lessens COVID-19 risk

Singapore, June 25 -- A team of researchers from the National University of Singapore (NUS) has invented a foldable tent-like device that serves as a physical shield to reduce the risk of exposure to ... Read More


Japanese firm repurposes hypertension vaccine as a potential COVID-19 vaccine

The Osaka, June 25 -- based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first half of 2021 if it can overcome supply chain and production hurdles. Co... Read More